logo
Plus   Neg
Share
Email

Sanofi: Trials Show Positive Topline Results In Acid Sphingomyelinase Deficiency

Sanofi (SNYNF,SNY) said, Olipudase alfa showed positive results in two clinical trials in the treatment of acid sphingomyelinase deficiency in adult and pediatric patients. The randomized Phase 2/3 trial enrolled 36 adult patients across 24 centers in 16 countries.

The company said these results will be submitted to future medical meetings and will form the basis of global regulatory submissions expected to begin the second half of 2021.

Acid sphingomyelinase deficiency is a rare potentially life-threatening disease for which no treatments are approved.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Lowe's (LOW) is temporarily increasing wages of its employees. The latest move by the hardware retailer is to help its employees cope with the economical effects caused by the ongoing COVID-19 pandemic. The company has hiked salary by $2 per hour for all full-time, part-time, and seasonal hourly associates,... Amazon.com Inc. (AMZN) Founder and CEO Jeff Bezos is donating $100 million to food banks across the U.S. to support poor people who cannot afford food during this coronavirus crisis. Bezos made a $100 million gift to Feeding America, one of the largest U.S. nonprofit focused on food security. Feeding... Facebook on Thursday shared an update on its $100 million small-business grants program announced in March, saying that it will provide $40 million in grants to 10,000 U.S. small businesses that were impacted by the coronavirus pandemic. In March, the social media giant said it is offering $100 million in cash grants and ad credits for up to 30,000 eligible small businesses.
Follow RTT
>